Accelerating at a CAGR of over 5%, the antimicrobial susceptibility testing market is expected to grow by post an incremental growth of $ 936.87 mn over the next five years. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers to provide growth projections and insights. This analytical examination of the market will enable businesses to plan and set the path for future growth prospects.
Rely on our business insights to implement a COVID-19 Recovery Plan: Request for Free Sample Report
Antimicrobial Susceptibility Testing Market: Market Segments and Key Trends
The Bone-anchored Hearing Aids Market market is segmented by Application (Clinical diagnostics, Drug discovery and development, and Others) and Geography (North America, Europe, Asia, and ROW). North America led the market with 40% of the market growth set to originate from this region during the forecast period. Stringent regulatory policies is one of the challenges that will need to be overcome to drive growth. This research report provides market share projections of each segment along with a detailed analysis of all the factors that are likely to boost growth within specific regions as well as global markets.
Antimicrobial Susceptibility Testing Market: Top Drivers to Boost Demand
The Increased use of antimicrobial susceptibility testing by biopharmaceutical companies is one of the primary factors driving the growth of the antimicrobial susceptibility testing market. The report provides a detailed study of all the factors that are likely to boost the market. An understanding of the key drivers will enable clients to leverage growth opportunities to their advantage with a view to short-term and long-term business goals.
Vendor Analysis: Accelerate Diagnostics Inc., ALIFAX Srl and Becton, Dickinson and Co. are key growth contributors
The market is fragmented. The research report provides insights into the top market player and their product portfolio along with pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Accelerate Diagnostics Inc., ALIFAX Srl, Becton, Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories, Inc, Bruker Corp., Danaher Corp., Merck KGaA, SDI Group plc, and Thermo Fisher Scientific Inc. are some of the major market participants.
For more insights on this market: Download a Free Sample Report
Antimicrobial Susceptibility Testing Market: Key Highlights of the Report for 2021-2025
The report provides insights into the following FAQs:
The antimicrobial susceptibility testing market is expected to grow by $ 936.87 mn, accelerating at a CAGR of almost 5% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of antimicrobial therapeutics, prevalent market forces, trends, and drivers which are likely to impact the market in focus.
Antimicrobial Susceptibility Testing Market: Receive Free Sample Report
Antimicrobial Susceptibility Testing Market: Segmentation by Application
This report provides a detailed analysis of the market by Application (Clinical diagnostics, Drug discovery and development, and Others) and Geography (North America, Europe, Asia, and ROW). This research report will provide insights into the current market share of each segment along with growth projections for the next five years. In addition, the report also offers a detailed impact analysis of various trends, drivers, and challenges which are likely to influence market growth during the forecast period. These insights are expected to equip clients with reliable information based upon which they can design a growth strategy for their business and area of operations.
Antimicrobial Susceptibility Testing Market: Vendor Analysis
The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Accelerate Diagnostics Inc., ALIFAX Srl, Becton, Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories, Inc, Bruker Corp., Danaher Corp., Merck KGaA, SDI Group plc, and Thermo Fisher Scientific Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with a pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
